Jci_page_head_homepage_01 Jci_page_head_homepage_02
Mohit Kapoor, Shangxi Liu, Xu Shi-wen, Kun Huh, Matthew McCann, Christopher P. Denton, James R. Woodgett, David J. Abraham, Andrew Leask
Published in Volume 118, Issue 10
J Clin Invest. 2008; 118(10):3279–3290 doi:10.1172/JCI35381
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 10
Loss of GSK-3β results in increased β-catenin, which is responsible for ET-1 overexpression.

(A and B) β-Catenin protein expression. Western blot analysis showed a significant (P < 0.05) increase in the expression of β-catenin in day 7 wounds and dermal fibroblasts of Gsk3b-CKO compared with GSK-3β C mice. Representative data for n = 4 animals per group are shown. (C) siRNA recognizing β-catenin reduces β-catenin protein expression in Gsk3b-CKO fibroblasts. Transfection of Gsk3b-CKO fibroblasts with siRNA recognizing β-catenin, compared with control siRNA, reduced the expression of β-catenin as revealed by Western blot analysis with anti–β-catenin antibody. Hours after transfection are indicated. (D and E) siRNA recognizing β-catenin reduces ET-1 protein and mRNA expression in Gsk3b-CKO fibroblasts. Forty-eight hours after transfection with control or β-catenin siRNA, Gsk3b-CKO fibroblasts were examined for ET-1 protein production by Western blot analysis with anti–ET-1 antibody or by real-time PCR to detect ET-1 mRNA. Fibroblasts from 6 mice were used. *P < 0.05. (F) Model showing effect of loss of GSK-3β expression on tissue repair in vivo.